Sirtuin 1 promotes the growth and cisplatin resistance of endometrial carcinoma cells: a novel therapeutic target. (Q38835509)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26367491%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

title

Sirtuin 1 promotes the growth and cisplatin resistance of endometrial carcinoma cells: a novel therapeutic target (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26367491%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

main subject

endometrial carcinoma

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26367491%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Tsutomu Miyamoto

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26367491%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Hirofumi Ando

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26367491%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

7

Tanri Shiozawa

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26367491%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

author name string

Yasushi Yamada

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26367491%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

David Hamisi Mvunta

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26367491%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Hisanori Kobara

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26367491%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

publication date

14 September 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26367491%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

published in

Laboratory Investigation

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26367491%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

volume

95

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26367491%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26367491%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

page(s)

1363-1373

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26367491%20AND%20SRC:MED&resulttype=core&format=json

Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies

24 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2015.119

Plasma adiponectin concentrations in relation to endometrial cancer: a case-control study in Greece

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2015.119

Regulation of Caenorhabditis elegans lifespan by sir-2.1 transgenes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2015.119

The retardation of aging by caloric restriction: studies in rodents and primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2015.119

The SIR2/3/4 complex and SIR2 alone promote longevity in Saccharomyces cerevisiae by two different mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2015.119

Sirtuins: Sir2-related NAD-dependent protein deacetylases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2015.119

Requirement of NAD and SIR2 for life-span extension by calorie restriction in Saccharomyces cerevisiae

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2015.119

hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2015.119

SIRT1: recent lessons from mouse models.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2015.119

Function of the SIRT1 protein deacetylase in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2015.119

Expression of DBC1 and SIRT1 is associated with poor prognosis for breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2015.119

Dating the endometrial biopsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2015.119

Estrogen-induced proliferation of normal endometrial glandular cells is initiated by transcriptional activation of cyclin D1 via binding of c-Jun to an AP-1 sequence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2015.119

Laser-captured microdissection-microarray analysis of the genes involved in endometrial carcinogenesis: stepwise up-regulation of lipocalin2 expression in normal and neoplastic endometria and its functional relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2015.119

Discovery of indoles as potent and selective inhibitors of the deacetylase SIRT1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2015.119

Negative control of p53 by Sir2alpha promotes cell survival under stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2015.119

p53 gene mutations in human endometrial carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2015.119

The SIR2 gene family, conserved from bacteria to humans, functions in silencing, cell cycle progression, and chromosome stability

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2015.119

Relationship between the expression of cyclins/cyclin-dependent kinases and sex-steroid receptors/Ki67 in normal human endometrial glands and stroma during the menstrual cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2015.119

SIRT1 is essential for oncogenic signaling by estrogen/estrogen receptor α in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2015.119

Expression of SIRT1 and cortactin is associated with progression of non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2015.119

High SIRT1 expression is a negative prognosticator in pancreatic ductal adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2015.119

Up-regulation of c-MYC and SIRT1 expression correlates with malignant transformation in the serrated route to colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2015.119

SIRT1 is significantly elevated in mouse and human prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2015.119

PTEN acetylation modulates its interaction with PDZ domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2015.119

The deacetylase SIRT1 promotes membrane localization and activation of Akt and PDK1 during tumorigenesis and cardiac hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2015.119

Emerging Roles of SIRT1 in Cancer Drug Resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2015.119

Active regulator of SIRT1 cooperates with SIRT1 and facilitates suppression of p53 activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2015.119

Acetylation of p53 inhibits its ubiquitination by Mdm2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2015.119

SIRT1-mediated FoxO1 deacetylation is essential for multidrug resistance-associated protein 2 expression in tamoxifen-resistant breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2015.119

Mechanism and functional consequences of loss of FOXO1 expression in endometrioid endometrial cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2015.119

Deacetylation of FOXO3 by SIRT1 or SIRT2 leads to Skp2-mediated FOXO3 ubiquitination and degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2015.119

The sirtuin inhibitor tenovin-6 upregulates death receptor 5 and enhances cytotoxic effects of 5-fluorouracil and oxaliplatin in colon cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2015.119

SirT1 is an inhibitor of proliferation and tumor formation in colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2015.119

SIRT inhibitors induce cell death and p53 acetylation through targeting both SIRT1 and SIRT2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2015.119

Sirtuin 1 facilitates chemoresistance of pancreatic cancer cells by regulating adaptive response to chemotherapy-induced stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2015.119

SIRT1 inhibition in pancreatic cancer models: contrasting effects in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2015.119

Melatonin prevents cell death and mitochondrial dysfunction via a SIRT1-dependent mechanism during ischemic-stroke in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2015.119

Inhibition of SIRT1 impairs the accumulation and transcriptional activity of HIF-1α protein under hypoxic conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2015.119

Concurrent regulation of AMP-activated protein kinase and SIRT1 in mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2015.119

Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2015.119

Dysregulation of the miR-34a-SIRT1 axis inhibits breast cancer stemness

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2015.119

Tumor estrogen content and clinico-morphological and endocrine features of endometrial cancer

21 January 2018

1 reference

12 December 2020

Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium

1 reference

12 December 2020

Intratumoral heterogeneous expression of p53 correlates with p53 mutation, Ki-67, and cyclin A expression in endometrioid-type endometrial adenocarcinomas

1 reference

12 December 2020

Expression of SIRT1 is associated with lymph node metastasis and poor prognosis in both operable triple-negative and non-triple-negative breast cancer

1 reference

12 December 2020

Inhibition of SIRT1 combined with gemcitabine therapy for pancreatic carcinoma

1 reference

12 December 2020

An epidemiological investigation of cancer of the endometrium

1 reference

12 December 2020

Clinical implications of insulin-like growth factors through the presence of their binding proteins and receptors expressed in gynecological cancers

1 reference

12 December 2020

Diet, body size, physical activity, and the risk of endometrial cancer.

1 reference

12 December 2020